0,1,2,3,4
Dovepress,,,,in silico epitope-based peptide vaccine design
Table 3 Kolaskar and Tongaonkar antigenicity analysis,,,,
Number,Start position,End position,Peptide,Peptide length
1,4,12,clcPVPglK,9
2,14,21,sTgFVYFn,8
3,26,32,DVncngY,7
4,34,40,hnsVaDV,7
5,54,84,nlKsgViVFKTlQYDVlFYcsnsssgVlDTT,31
6,86,99,PFgPssQPYYcFin,14
7,104,126,TThVsTFVgilPPTVreiVVarT,23
